New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 21, 2012
17:18 EDTIDXXIDEXX announces FTC preliminary approval of consent agreement
IDEXX Laboratories announced that the commissioners of the U.S. FTC have preliminarily approved the consent agreement previously reached between the company and the staff of the FTC Bureau of Competition. Pursuant to FTC protocol, a proposed draft complaint and the proposed consent agreement, which includes a draft consent order, will be placed on public record for a 30-day comment period, after which the FTC will evaluate any public comment before finalizing the agreement and order. "While we admit no wrongdoing and continue to believe that our distribution practices do not violate the antitrust laws as these same practices have been upheld in previous litigation victories, this is another important step toward final resolution of the multi-year FTC investigation, which we now expect to occur early in 2013," the company said.
News For IDXX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 29, 2015
07:55 EDTIDXXZoetis could make a bid for IDEXX, says Canaccord
Canaccord hosted investor meetings with IDEXX (IDXX) management, who spoke about new product launches and their market share in light of competitive concerns. Management declined to comment on Zoetis' (ZTS) potential interest in scaling up its animal health diagnostics business, said Canaccord, which noted that it thinks Zoetis could make a bid for IDEXX. Canaccord reiterated its Buy rating and $80 price target on IDEXX shares, citing its cash on the balance sheet, low interest rates, recent CEO stock purchases and new product cycles that skew the risk/reward to the upside.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use